Mitochondria are important target organelles in cell death signaling pathways in different experimental and disease models including endoplasmic reticulum (ER) stress or metabolic stress induced cell death.^[@bib1],\ [@bib2]^ In *in-vivo* or *in-vitro* models, sustained activation of c-Jun N-terminal kinase (JNK) is an effector signaling molecule strongly associated with cell death.^[@bib3]^ The mechanism of sustained JNK activation by different pathways depends on the context of the experimental model used and activation of signaling molecules including source of reactive oxygen species (ROS). In acetaminophen (APAP)-induced hepatocyte death or acute liver failure where mitochondria are the primary targeted organelles, we found massive activation of JNK within a short period, and sustained JNK activation accompanied the release of ROS from mitochondria leading to upstream activation of the mitogen-activated protein (MAP) kinase cascade.^[@bib4]^ The activation loop was initiated and amplified by binding of activated JNK (P-JNK) to the outer mitochondrial membrane protein Sab (SH3 homology associated BTK binding protein) and subsequent inhibition of mitochondrial respiration.^[@bib5]^ Silencing of Sab inhibited translocation of P-JNK to mitochondria and sustained activation of JNK, and prevented APAP or galactosamine/tumor necrosis factor (TNF)-*α* induced mouse liver injury and hepatocyte death.^[@bib5]^ Furthermore, others have shown that inhibition of P-JNK binding to Sab using a Sab~Kim1~ peptide corresponding to the P-JNK binding site of Sab prevented ischemic necrosis in heart^[@bib6]^ and brain.^[@bib7]^

In severe ER stress induced by tunicamycin or brefeldin A (BFA), apoptotic cell death is preceded by mitochondrial cytochrome *c* release and caspase activation. In different ER stress studies, several signaling mechanisms linking ER stress and mitochondrial cell death pathway have been proposed.^[@bib8],\ [@bib9],\ [@bib10]^ These include IRE1*α*→TRAF2→ASK1→JNK, and PERK→CHOP→ERO1*α*→IP3R→CaMKII-*γ* with both pathways resulting in activation of BH3 only domain proteins, generation of mitochondrial derived ROS, impaired insulin receptor signaling and induction of Fas expression.^[@bib11],\ [@bib12],\ [@bib13],\ [@bib14],\ [@bib15]^ Malfolded protein initiates ER stress and unfolded protein response (UPR) is activated through IRE1*α*, PERK, and activating transcription factor 6 (ATF-6) signaling pathways. Malfolded protein induces dimerization of IRE1*α*, which activates the kinase domain, initiating the MAP kinase pathway via recruitment of TRAF2, RIP1, and ASK1, and also activates the endonuclease domain, which splices X-box binding protein 1 (XBP1) mRNA to spliced (s) XBP1 for UPR gene expression.^[@bib16]^ Activation of MAP kinase, downstream of IRE1*α* dimerization, is an early event occurring before changes of global gene expression mediated by sXBP1 or the ER generation of ROS by the P-PERK→CHOP→ERO1*α*.^[@bib17],\ [@bib18]^ JNK activation is sustained in severe ER stress-induced cell death, though the mechanism of how JNK activation is sustained has yet to be defined. Furthermore, the contribution of ROS and its source (mitochondrial or ER) to sustained JNK activation and the contribution of P-JNK interaction with mitochondria to ER stress-induced cell death has not been defined. In primary mouse hepatocytes (PMHs), tunicamycin (5 *μ*g/ml) inhibition of protein glycosylation leads to accumulation of malfolded protein followed by Ca^2+^ release into cytosol in the early phase of ER stress.^[@bib19],\ [@bib20],\ [@bib21]^ As cell death is delayed, the role of early calcium release on mitochondria and cell death are not well understood. However, prolonged severe ER stress depletes ER calcium stores, further impairing protein folding in the ER. BFA primarily impedes protein transport from the endoplasmic reticulum to the Golgi complex resulting in markedly dilated endoplasmic reticulum.^[@bib22]^

In this paper, we have identified that P-JNK interaction with Sab is a key event in the perturbation of mitochondrial ATP producing respiration in tunicamycin or BFA-induced ER stress and has a major role in cell death induced by ER stress in hepatocytes and HeLa cells.

Results
=======

ER stress inhibits mitochondrial respiration
--------------------------------------------

Tunicamycin and BFA are widely used ER stress inducers. Tunicamycin inhibits protein glycosylation in the ER leading to ER stress due to protein malfolding. BFA causes a rapid accumulation of proteins within the ER and collapse of the Golgi stacks. We examined the effect of a range of tunicamycin concentrations on hepatocyte viability and found dose related toxicity with minimal effect at 10 *μ*g/ml and marked effect at 20 *μ*g/ml (65% cell death at 24 h, [Figure 1a](#fig1){ref-type="fig"}), which was preceded by caspase 3 activation and cytochrome *c* release at 4 h ([Figures 1b and c](#fig1){ref-type="fig"}). Tunicamycin-induced cell death by SYTOX-green nuclear staining did not appear until after 8 h. To investigate the involvement of mitochondria in ER stress induced PMH apoptosis, we examined the real-time changes of cellular and mitochondrial oxygen consumption rate (OCR). Cellular OCR declined gradually over 2 h in tunicamycin (20 *μ*g/ml) treated PMH ([Figure 1d](#fig1){ref-type="fig"}). Tunicamycin 20 *μ*g/ml significantly decreased mitochondrial oxidative-phosphorylation (Ox-Phos) and reserve oxidative capacity (reserve-capacity) after 1 h and 2 h of treatment, whereas proton leak, which functions to dampen ROS generation,^[@bib23]^ was increased at 1 h but decreased significantly at 2 h of treatment ([Figure 1e](#fig1){ref-type="fig"}). Non-mitochondrial OCR was not changed significantly (not shown). Consistent with tunicamycin-induced ER stress, BFA (10--20 *μ*g/ml)-induced ER stress also increased cell death ([Supplementary Figure S1A](#sup1){ref-type="supplementary-material"}), and inhibited mitochondrial OCR of PMH ([Supplementary Figure S1B](#sup1){ref-type="supplementary-material"}). In addition, ER stress induced by tunicamycin or BFA increased HeLa cell death ([Supplementary Figures S2A and S3A](#sup1){ref-type="supplementary-material"}) and inhibited mitochondrial OCR ([Supplementary Figure S4](#sup1){ref-type="supplementary-material"}).

Involvement of JNK in ER stress induced inhibition of mitochondrial respiration and cell death
----------------------------------------------------------------------------------------------

Next, we looked at the time course of activation of ER stress transducers. As expected, the ER resident stress sensors PERK (P-PERK) ([Figure 2b](#fig2){ref-type="fig"}) and ER stress response protein expression (CHOP) ([Figure 2b](#fig2){ref-type="fig"}) increased after 4--8 h, whereas JNK was activated earlier and was sustained ([Figure 2a](#fig2){ref-type="fig"}). Activation of JNK (P-JNK) as a downstream target of IRE1*α* kinase domain activation ([Figure 2a](#fig2){ref-type="fig"}), and spliced XBP1 mRNA ([Figure 3c](#fig3){ref-type="fig"}) as a response to activation of endonuclease domain of IRE1*α* increased after 1--8 h. Inhibition of JNK activation by SP600125 (JNKi) selectively and significantly blocked sustained P-JNK activation, whereas SP600125 did not prevent P-PERK activation and CHOP expression ([Figure 2b](#fig2){ref-type="fig"}). To investigate the link between tunicamycin-induced P-JNK activation and involvement of mitochondria in ER stress, we examined the changes of cellular and mitochondrial OCR induced by tunicamycin with or without JNKi. Tunicamycin inhibition of cellular and mitochondrial Ox-Phos OCR was significantly prevented by SP600125 (JNKi) co-treatment ([Figure 2c](#fig2){ref-type="fig"}), but ER stress induced inhibition of anaerobic glycolysis (extracellular acidification rate (EACR)) after carbonyl cyanide 3-chlorophenylhydrazone (CCCP) injection was not affected ([Supplementary Figure S5](#sup1){ref-type="supplementary-material"}). Moreover, JNKi inhibited caspase 3 cleavage (not shown) and significantly prevented cell death ([Figure 2d](#fig2){ref-type="fig"}). JNK activation by BFA-induced ER stress in PMH was inhibited by JNKi ([Supplementary Figure S1C](#sup1){ref-type="supplementary-material"}). JNKi also prevented tunicamycin or BFA induced ER stress-mediated HeLa cells death ([Supplementary Figures S2B and S3B](#sup1){ref-type="supplementary-material"}) by inhibiting ER stress-mediated JNK activation ([Supplementary Figures S2C and S3C](#sup1){ref-type="supplementary-material"}). Therefore, JNK is a key mediator of tunicamycin or BFA-induced impairment of mitochondrial respiration and apoptosis.

Involvement of mitochondrial Sab in ER stress inhibition of mitochondrial respiration and induction of cell death
-----------------------------------------------------------------------------------------------------------------

P-JNK activation and translocation to mitochondrial Sab have a key role in APAP and TNF/galactosamine induced hepatotoxicity and in ischemia-reperfusion injury of brain and heart. Activation and translocation of JNK to mitochondria have been shown to inhibit mitochondrial state 3 respiration and respiratory-control-ratio (RCR) in the APAP induced hepatocyte injury model^[@bib4]^ and in HeLa cells.^[@bib24]^ Knockdown of Sab by shRNA prevents the hepatic necrosis and PMH death, and blocking of Sab-P-JNK binding by Sab~KIM1~ peptide prevents brain and cardiac ischemic necrosis.^[@bib5],\ [@bib6],\ [@bib7]^ Thus, to further define the role of JNK in inhibition of mitochondrial Ox-Phos by ER stress in PMH, we examined the effect of silencing of Sab expression on tunicamycin (20 *μ*g/ml) induced ER stress response, cellular and mitochondrial respiration, and cell death. Knockdown of Sab did not significantly change the tunicamycin-induced intensity and chronology of P-PERK activation, CHOP, sXBP1 mRNA, (and glucose-regulated protein 78 kDa (GRP78), not shown) expression ([Figures 3a and c](#fig3){ref-type="fig"}). Basal level of ER stress sensors IRE1*α* (not shown), PERK protein levels were not changed by silencing of Sab ([Figure 3a](#fig3){ref-type="fig"}). Thus, the ER stress response was not perturbed by silencing of Sab. In shlacZ control PMH, JNK activation was rapidly and significantly enhanced above basal level at 15 min (initial activation) after tunicamycin treatment, further increasing from 30 to 60 min followed by a gradual decline to 8 h. In Sab-silenced PMH and HeLa cells, initial JNK activation (15 min) was similar to the intensity in tunicamycin-treated shlacZ control PMH, but thereafter P-JNK activation was significantly inhibited ([Figures 3a and b](#fig3){ref-type="fig"} and [Supplementary Figure S2D](#sup1){ref-type="supplementary-material"}). Silencing Sab expression protected against tunicamycin-induced cytochrome *c* release ([Supplementary Figure S6](#sup1){ref-type="supplementary-material"}) and PMH death ([Figure 3d](#fig3){ref-type="fig"}) and HeLa cell death ([Supplementary Figure S2E](#sup1){ref-type="supplementary-material"}), and significantly prevented tunicamycin-induced inhibition of cellular and mitochondrial OCR ([Figure 3e](#fig3){ref-type="fig"}, [Supplementary Figure S4](#sup1){ref-type="supplementary-material"}). This suggested that ER stress targets and inhibits mitochondrial respiration through initial P-JNK activation from ER, which is then sustained by the interaction of P-JNK with mitochondrial Sab. Silencing of Sab in PMH and HeLa cells also prevented BFA-induced ER stress-mediated sustained JNK action ([Supplementary Figures S1D and S3D](#sup1){ref-type="supplementary-material"}) and cell death ([Supplementary Figures S1E and S3E](#sup1){ref-type="supplementary-material"}) but not by eliminating ER stress ([Supplementary Figures S1F and S3F](#sup1){ref-type="supplementary-material"}). Decreased mitochondrial OCR by BFA-induced ER stress was also prevented in Sab-silenced PMH and HeLa cells ([Supplementary Figures S1G and S4](#sup1){ref-type="supplementary-material"}).

To further investigate whether tunicamycin induced P-JNK activation and inhibition of mitochondrial respiration was dependent on mitochondrial protein Sab, we measured the cellular and mitochondrial OCR of PMH incubated with tunicamycin with either membrane permeant scrambled peptide or Sab~Kim1~ peptide.^[@bib25]^ Sab~Kim1~ peptide prevented tunicamycin-induced inhibition of cellular OCR and mitochondrial Ox-Phos and prevented the decrease of mitochondrial reserve-capacity ([Figure 3f](#fig3){ref-type="fig"}). To rule out a direct effect of tunicamycin on mitochondria, we measured OCR in isolated mouse liver mitochondria and observed no inhibition ([Supplementary Figure S7](#sup1){ref-type="supplementary-material"}).

As JNK can be activated by ROS and because mitochondrial dysfunction can result in ROS production, we next examined the effect of antioxidant treatment in the link between ER stress and mitochondrial perturbation and cell death. Antioxidant butylated hydroxyanisole (BHA) significantly inhibited sustained JNK activation from 30 min to 8 h but did not inhibit the initial (15 min) activation ([Figure 4b](#fig4){ref-type="fig"}), which is likely derived directly from the ER. P-PERK activation, CHOP and GRP78 expression were not significantly changed by BHA pretreatment ([Figure 4a](#fig4){ref-type="fig"}). BHA also inhibited cell death ([Figure 4c](#fig4){ref-type="fig"}). This suggested that mitochondrial oxidants (ROS) contribute to P-JNK activation after the initial ER stress activation. In tunicamycin-induced ER stress models, the source of ROS can be contributed to by ERO1*α* in ER or by inhibition of mitochondrial electron transport. The lack of inhibition of initial JNK activation by BHA favors the latter. Therefore, we examined the generation of ROS from isolated mitochondria exposed to recombinant active P-JNK by measuring superoxide (O~2~^•−^) production. ROS was increased after exposure to P-JNK plus ATP (but not by either one alone). The requirement for ATP supports earlier work showing that P-JNK phosphorylates Sab.^[@bib26]^ ROS was significantly blocked by Sab~Kim1~ peptide but not by scrambled peptide ([Figure 4d](#fig4){ref-type="fig"}). Prevention of sustained P-JNK activation by silencing of Sab or by BHA suggests that mitochondria are the major source of ROS and that ROS promote the sustained JNK activation through a self-amplifying mechanism that leads ultimately to cell death ([Figure 4f](#fig4){ref-type="fig"}).

As ER Ca^2+^ release in response to tunicamycin could affect mitochondrial respiration, we assessed the role of Ca^2+^. The inhibition of PMH mitochondrial respiration by tunicamycin and sustained JNK activation was not affected by CaMKII inhibitor, calcium uniporter inhibitor or chelation of calcium ([Supplementary Figure S8](#sup1){ref-type="supplementary-material"}), indicating that the early inhibitory effects of tunicamycin on mitochondrial respiration are dependent on the JNK--Sab interaction but independent of calcium. Of note inositol 1,4,5-trisphosphate (IP3) induced ER calcium release increased OCR ([Supplementary Figure S8](#sup1){ref-type="supplementary-material"}). As Ca^2+^ enhanced mitochondrial respiration, we determined the effect of Ca^2+^ on the time course and extent of superoxide production by isolated mitochondria exposed to active JNK (JNK~(a)~) or inactive JNK (JNK~(m)~). Ca^2+^ (50 nM) increased the level and duration of MitoSOX fluorescence in the presence of active but not with inactive JNK ([Figure 4e](#fig4){ref-type="fig"}). Ca^2+^ also increased ROS generation in antimycin A-treated mitochondria (not shown).

Discussion
==========

The goal of the present study was to elucidate the role of the P-JNK→mitochondrial Sab→ROS self-amplification loop in ER stress induced mitochondrial dysfunction and cell death. In many cellular contexts it has been recognized that ER and mitochondrial stress and dysfunction accompany each other, but the mechanism for the interplay of these two closely associated organelles in the cell death response to ER stress is poorly understood.^[@bib27],\ [@bib28]^ We and others have described an important self-amplification loop involving JNK activation by toxins, TNF, and ischemia-reperfusion leading to binding of P-JNK to Sab on the outer mitochondrial membrane, which then promotes mitochondrial ROS production by a mechanism not yet fully understood.^[@bib4],\ [@bib5]^ ROS release then further activates MAPK cascade, and the self-amplification results in sustained JNK activation leading either to ROS mediated mitochondrial permeability transition (MPT)-induced necrosis (as seen in APAP toxicity) or B-cell lymphoma 2 (Bcl2) family mediated mitochondrial outer membrane permeabilization (MOMP)-induced apoptosis (as seen in the TNF/galactosamine model of liver injury).

JNK is known to be activated by ER stress through the IRE1*α* pathway,^[@bib11]^ but the interplay with mitochondria and the mechanism for sustained JNK activation in ER stress is not known. Therefore, we hypothesized that the initial JNK activation in the ER is followed by its interplay with mitochondrial Sab, leading to impaired mitochondrial function and amplification of mitochondrial ROS release and that this self-amplification loop has a key role in ER stress-induced cell death. To test this hypothesis, we induced ER stress in PMH and HeLa cells using tunicamycin, a widely used specific inducer of ER stress through inhibition of protein glycosylation and unfolded protein accumulation or BFA, an inhibitor of protein transport from the endoplasmic reticulum to the Golgi. Immediate JNK activation as fast as 15 min after tunicamycin or BFA treatment has been shown and several studies have confirmed that initial JNK activation is IRE1*α* dependent. In the present study, we first identified that the ER stress induced rapid decrease of mitochondrial Ox-Phos, which was not due to a direct effect of ER stress inducers on mitochondria. This rapid impairment in respiration preceded caspase 3 activation and cell death. Cytochrome *c* release pointed to mitochondrial dependent apoptosis. The rapid impairment in respiration was JNK and ROS dependent as both JNKi and BHA prevented this effect of ER stress inducers. Furthermore, knockdown of Sab as well as the inhibitory Sab~KIM1~ peptide blocked the effect of ER stress on mitochondrial respiration. When Sab was knocked down or inhibited, sustained JNK activation did not occur but the very initial JNK activation, presumably due to IRE1*α* pathway, was not Sab dependent. Importantly, neither JNKi, BHA, or Sab knockdown inhibited ER stress signaling through IRE1α (sXBP1) or PERK (CHOP). Furthermore, tunicamycin- or BFA-induced cell death, which was apoptotic as expected, was inhibited by JNKi, BHA, and Sab knockdown indicating that the interplay of JNK with mitochondrial Sab was required for cell death. The early mitochondrial respiratory impairment resulting from the interplay of P-JNK and Sab caused increased ROS production. Superoxide production was demonstrated by addition of P-JNK and ATP directly to isolated mitochondria and was specifically inhibited by Sab~KIM1~ peptide. It should be noted that although this JNK effect was previously thought to require damaged mitochondria,^[@bib29]^ we found that the ROS response occurred in normal liver mitochondria exposed to activated JNK. In this study, we did not examine the specific complexes involved although others have demonstrated that complex I and III are inhibited in other experimental contexts.^[@bib24]^ The mechanism for how interplay of JNK and Sab leads to impaired respiration is currently under investigation. JNK is known to phosphorylate Sab on the C terminus^[@bib26]^ and we found that ATP was required for P-JNK to induce ROS production in isolated mitochondria. How JNK phosphorylation of the cytoplasmic C-terminal side of this protein with one predicted transmembrane domain leads to inhibition of inner membrane electron transport is currently unknown. Nevertheless, it is reasonable to conclude that this leads to the observed impairment of respiration and increase ROS, which then continues to sustain activation of the MAPK cascade, thereby explaining why silencing Sab inhibits sustained JNK activation in ER stress model as well as in APAP and TNF/galactosamine models, triggered by direct toxin effects on mitochondria or TNF receptor signaling, respectively.

We attempted to assess the role of Ca^2+^ in the tunicamycin-induced impairment of mitochondrial respiration and found through the use of various inhibitors that Ca^2+^ was dispensable. However, we observed that IP3 mediated calcium release expanded the mitochondrial respiring pool. This is consistent with prior work showing that Ca^2+^ release from ER and uptake by mitochondria can activate pyruvate, *α*-ketoglutarate, and isocitrate dehydrogenases.^[@bib30],\ [@bib31],\ [@bib32],\ [@bib33]^ Therefore, we considered the possibility that ER stress induced Ca^2+^ release, and uptake by mitochondria could promote or amplify ROS production when electron transport is blocked by the JNK-Sab mediated effect on mitochondria. Indeed, in isolated mitochondria, addition of calcium amplified the effect of P-JNK on ROS production. The adverse effects of Ca^2+^ on mitochondria therefore presumably require an increased substrate utilization leading to build-up of reduced complexes due to inhibition by the JNK-Sab effect. Thus, although calcium did not contribute to the JNK-dependent respiratory inhibition, it contributes to the ROS production when electron transport is inhibited.

A final question of importance, not directly addressed in our study, is precisely how sustained JNK activation by the mitochondrial Sab cycle leads to apoptotic cell death. In the APAP model of hepatocyte necrosis, the JNK-Sab interplay leads to amplification of mitochondrial ROS sufficient to induce the MPT.^[@bib34]^ However, in apoptosis it is likely that the pathway involves MOMP leading to cytochrome *c* release and caspase activation. JNK is known to phosphorylate pro-apoptotic Bcl~2~ family members such as Bax and Bim and antiapoptotic members such as Bcl-extra large (X~L~) and myeloid cell leukemia sequence 1 (Mcl-1), the former leading to activation and the latter to inhibition. The ultimate outcome is an imbalance of the Bcl~2~ family leading to permeabilization and release of cytochrome *c* and other intermembrane proteins.^[@bib35],\ [@bib36],\ [@bib37],\ [@bib38],\ [@bib39],\ [@bib40],\ [@bib41]^

In summary, we demonstrated that tunicamycin or BFA, a specific chemical inducer of severe, lethal ER stress in cultured hepatocytes and HeLa cells, caused a rapid impairment of mitochondrial respiration, which is dependent on sustained JNK activation. JNK interacts with Sab, which leads to the inhibition of respiration and ROS production, the latter amplified by calcium release from ER, creating a self-amplification cycle with sustained JNK activation ultimately leading to apoptosis ([Figure 4f](#fig4){ref-type="fig"}). Tunicamycin or BFA initiates the process by triggering direct ER-induced P-JNK and Ca^2+^ release, which target mitochondria to initiate the P-JNK→Sab→ROS cycle. We would like to underscore that our studies represent a model of acute severe chemical induced ER stress, which leads to a large apoptotic effect. Therefore, the extent to which this mechanism contributes to sustained JNK activation, mitochondrial functional impairments and insulin resistance in less severe, nonlethal chronic ER stress, for example, due to overfeeding or excess saturated fatty acid, remains to be studied.

Materials and Methods
=====================

Reagents and animals
--------------------

P-JNK, PERK, P-PERK, CHOP, Cyt c (Cell Signaling Technology, Danvers, MA, USA), JNK and GRP-78 (Santa Cruz, Dallas, TX, USA), P-CaMKII (Novus, Santa Cruz), Gapdh and *β*-actin (Sigma Aldrich, St Louis, MO, USA), IRE1*α* (Abcam, Cambridge, MA, USA) and Sab (Proteintech, Abnova, Walnut, CA, USA) were used. DMSO, tunicamycin, BFA, BHA, Z-VAD-fmk (Sigma Aldrich), JNK inhibitor II (SP600125), Ru360, KN-93 (Calbiochem, EMD-Millipore, Billerica, MA, USA), recombinant JNK1*α*1/SAPK1c (active and inactive), JNK2*α*2/SAPK1*α* (active and inactive) (Upstate-Millipore, Billerica, MA, USA), BAPTA-AM (Invitrogen, Grand Island, NY, USA) were dissolved as described by the manufacturer. Tat-scrambled peptide (LPSVFGDVGAPSRLPEVSLSP-PRRRQRRKKRG-NH2) and Tat-Sab~KIM1~ peptide (GFESLSVPSPLDLSGPRVVAP-PRRRQRRKKRG-NH2) were purchased from Neo Peptide. Sab~KIM1~ peptide sequence was the same sequence as JNK binding KIM1 domain of mouse Sab protein. Peptide was dissolved in distilled water and stored in −80 °C. Male C57BL/6NHsd mice (6--8 weeks of age) were obtained from Harlan Bioproducts for Science Inc. (Indianapolis, IN, USA). Tunicamycin or BFA was dissolved in DMSO (final concentration 0.1%).

PMH isolation, culture, treatment and protein extraction
--------------------------------------------------------

PMHs from wild type or adenoviral shRNA pretreated C57BL/6N mice were isolated and cultured as described previously.^[@bib5]^ Briefly, 5 h after plating of isolated hepatocytes in seeding medium (DMEM/F12 supplemented with HEPES, [L]{.smallcaps}-methionine, [L]{.smallcaps}-glutamine, penicillin, streptomycin, NaHCO~3~, insulin, hydrocortisol, and FBS), the medium was changed to serum free DMEM/F12 culture medium and cells were rested overnight. To the resting medium tunicamycin or DMSO was added and incubated for 0.25, 0.5, 0.75, 1, 4, 8, 16, 24 h. At indicated times, hepatocytes were washed twice with DPBS and protein was extracted in RIPA lysis buffer supplemented with protease and phosphatase inhibitors. Whole cell lysate was spun at 20 000 × *g* at 4 °C for 15 min and supernatant was collected and stored in −80 °C.

Measurements of respiration by Seahorse XF24 analyzer
-----------------------------------------------------

PMH were isolated and seeded for 5 h in collagen coated 24 wells XF24 cell culture microplates. Cells were then rested overnight in serum free, phenol red free DMEM/F12 medium. Cells were then removed from the resting medium and washed twice with DMEM running medium (XF assay modified DMEM supplemented with 1 mM sodium pyruvate and 2.5 mM glucose, pH7.4) and incubated at 37 °C without CO~2~ for 1 h to allow cells to pre-equilibrate with the assay medium. Reagents and chemicals for respiratory stress testing were loaded onto XF24 extracellular flux assay plate. Reagent of interest, such as tunicamycin or BFA with or without inhibitors, was diluted in DMEM running medium and loaded into port-A. Oligomycin, CCCP or rotenone (Sigma Aldrich) diluted in DMEM running medium were loaded into port-B, port-C or port-D, respectively. Final concentration in XF24 cell culture microplates were Oligomycin 1 *μ*g/ml, CCCP 20 *μ*M or rotenone 20 *μ*M. Sequence of measurements was as follows unless otherwise described. Basal level of OCR was measured three times, and then port-A was injected and measured seven times for 1--2 h. The medium was mixed every 10 min without data acquisition if intervals of OCR measurements were longer than 10 min. At the end of continuous real-time measurement of cellular OCR, port-B, port-C or port-D was injected and OCR was measured two times after each injection to determine mitochondrial or non-mitochondrial contribution of OCR. All measurements were normalized to average of three measurements of basal (starting) level cellular OCR of each well. Each sample was measured in three to five wells. Experiments were repeated three to five times with different cell preparations. Mitochondrial oxidative-phosphorylation was determined by OCR before oligomycin injection minus OCR after oligomycin injection. Mitochondrial proton leak was determined by OCR after oligomycin injection minus OCR after rotenone injection. Non-mitochondrial OCR was determined by OCR after rotenone injection minus OCR of wells without cell. Mitochondrial reserved oxidative capacity was determined by OCR after CCCP injection minus OCR before oligomycin injection. Data were analyzed in groups of wells of each sample cell preparation and statistical analysis was calculated with ANOVA and *t*-test.

Measurements of ROS
-------------------

Mitochondria were isolated from wild-type mouse liver as shown before and resuspended in respiration buffer (70 mM sucrose, 220 mM mannitol, 10 mM KH~2~PO~4~, 5 mM MgCl~2~, 2 mM HEPES, 1 mM EGTA pH7.2) and kept [i]{.ul}n ice. 20 *μ*g of isolated mitochondria were diluted to 50 *μ*l in respiration buffer with 10 mM pyruvate/2 mM malate and loaded into each well of fluorescence microtiter plate (Corning, Corning, NY, USA) and kept on ice and covered to avoid exposure to light. For injection port, recombinant active JNK or mutated inactive JNK (Millipore, Billerica, MA, USA) 10 ng per well was diluted to 10 *μ*l in respiration buffer and preincubated with 600 *μ*M ATP (Sigma Aldrich) and scrambled or Sab~KIM1~ peptide 10 *μ*M at 25 °C for 30 min. P-JNK+ATP+peptide mix was diluted to 50 *μ*l per well in respiration buffer supplemented with 5 *μ*M MitoSOX red (Invitrogen) with or without 10 *μ*M FeTCPP (Sigma Aldrich). Basal fluorescence level of mitochondria at state II respiration was measured before injection of mixture from injection port, and then measured fluorescence level at 5 min interval using Omega fluorescence microplate reader. For experiments to determine effect of Ca^2+^ in mitochondrial ROS production, \[Ca^2+^\]~free~ was obtained by reciprocal dilution of Zero Free Calcium Buffer and 39 *μ*M Free Calcium Buffer (Invitrogen). 50 *μ*l of \[Ca^2+^\] 0 nM or 50 nM were loaded to microtiter plate on ice, and then 20 *μ*g of mitochondria diluted to 50 *μ*l in respiration buffer with 10 mM pyruvate/2 mM malate and 5 *μ*M MitoSOX was loaded to each well on ice and protect from light. Basal fluorescence intensity was measured for three time, and then 10 *μ*l of cocktail of 10 ng activated JNK (JNK~(a)~)or inactive JNK (JNK~(m)~) and 600 *μ*M ATP with or without 10 *μ*M FeTCPP was injected to each well. Fluorescence intensity difference of MitoSOX with or without FeTCPP was expressed as fluorescence intensity generated by binding of MitoSOX and superoxide (O~2~^•−^) produced from mitochondria.

Cell death assay
----------------

PMH were isolated and seeded as described above. At indicated times cell membrane impermeable SYTOX-green (1 *μ*mol/L; Invitrogen) and cell membrane permeable nuclear stain Hoechst 33258 (8 *μ*g/ml; Invitrogen) were incubated at 37 °C for 15 min. Dead cells were identified as SYTOX-green positive due to nuclear staining of impermeable dye. Dead cells were counted from a minimum of 1000 Hoechst 33258 stained cells.

Cleaved-caspase-3 immunocytochemistry and cytochrome *c* immunofluorescence staining
------------------------------------------------------------------------------------

PMH at indicated times were fixed in 3% neutral buffered formalin and permeabilized in 80% methanol. Cells were rinsed in PBS 10 min for three times and blocked in 5% BSA-PBS for 1 h at 25 °C. Cells were then incubated overnight at 4 °C with cleaved-caspase-3 antibody (Biocare, Concord, CA, USA) or cytochrome *c* antibody (Cell Signaling Technology). HRP-conjugated-secondary antibody (Biocare) and DAB (Pierce, Rockford, IL, USA) was used for chromogen development. Nuclei were counterstained with haematoxylin. Cleaved-caspase-3 positive PMH detected as brown colored precipitated DAB were counted from a minimum of 1000 cells. Alexa-488 conjugated-secondary antibody (Invitrogen) was used for laser scanning confocal microscopy (Zeiss 510) (63X magnification) imaging of cytochrome *c* fluorescence staining in PMH.

Immunoblot analysis
-------------------

30--50 *μ*g amount of protein of whole cell lysate extracts were loaded and separated on 7.5, 10, or 12% SDS polyacrylamide gels (Bio-Rad, Hercules, CA, USA) by electrophoresis. Subsequently, proteins were transferred to nitrocellulose membrane and blots were blocked with 5% (w/v) nonfat milk dissolved in Tris-buffered saline with Tween 20. The blots were then incubated with the primary and secondary antibodies. Finally, the proteins were detected by Luminol ECL reagent (Thermo Scientific, Waltham, MA, USA). All gels shown are representative from at least three experiments. Densitometric quantification and statistical analysis were determined by four to five experiments.

Reverse transcription PCR to measure XBP1 mRNA splicing
-------------------------------------------------------

At indicated time, medium was removed and PMH were quickly covered with RNAprotect cell reagent (Qiagen, Valencia, CA, USA), cell pellet was collected and RNA was isolated using RNA easy kit (Qiagen). 2 *μ*g of total RNA was used for reverse transcription PCR using One-step RT-PCR kit (Qiagen). XBP1(S) (spliced form) and XBP1 mRNA was determined by primers ACACGCTTGGGAATGGACAC and CCATGGGAAGATGTTCTGGG. The primers generate amplicons of XBP1(S) 145bp and XBP1 171bp.

Adenoviral shRNA preparation
----------------------------

BLOCK-iT Adenoviral RNAi Expression System (Invitrogen) was used as described before^[@bib42]^ to generate expression constructs for shRNAs targeting lacZ (shlacZ) and mouse Sab (shSab). The oligo sequences to synthesize the shlacZ construct are 5′-CACCGCTACACAAATCAGCGATTTCGAAAAATCGCTGATTTGTGTAG-3′ and 5′AAAACTACACAAATCAGCGATTTTTCGAAATCGCTGATTTGTGTAGC-3′. The oligo sequences for the shSab construct are 5′-CACCGGATGACAAGCGGCAGTTTGACGAATCAAACTGCCGCTTGTCATCC-3′ and 5′-AAAAGGATGACAAGCGGCAGTTTGATTCGTCAAACTGCCGCTTGTCATCC-3′. Mice (25 g) were tail-vein injected with 1 × 10^9^ infectious units (i.u.) of adenovirus expressing shRNA after purified with Vivapure Adenopack (Sartoriusstedim Biotech, Concord, CA, USA).

Biological replicates and statistical analysis
----------------------------------------------

A minimum of four biological replicates were considered for all cell-based studies. Statistical analyses were performed using the Student\'s *t*-test or ANOVA for two-way analysis of variance. *P*\<0.05 was defined as statistically significant.
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ATF-6

:   Activating transcription factor 6

ATP

:   Adenosine 5′-triphosphate

Bcl2

:   B-cell lymphoma 2

Bcl-X~L~

:   B-cell lymphoma-extra-large

BFA

:   brefeldin A

BHA

:   butylated hydroxyanisole

Ca^2+^

:   calcium

CaMKII-*γ*

:   calcium/calmodulin-dependent protein kinase II gamma

CCCP

:   Carbonyl cyanide 3-chlorophenylhydrazone

CHOP

:   DNA-damage-inducible transcript 3

EACR

:   extracellular acidification rate

ER

:   endoplasmic reticulum

ERO1*α*

:   endoplasmic reticulum oxidoreductin-1*α*

Fas

:   TNF receptor superfamily member

GRP78

:   glucose-regulated protein 78 kDa

IP3

:   inositol 1,4,5-trisphosphate

IP3R

:   inositol 1,4,5-trisphosphate receptor

IRE1*α*

:   Inositol-requiring enzyme-1*α*

JNK~(a)~

:   active JNK

JNK~(m)~

:   inactive JNK

JNK

:   c-Jun N-terminal kinase

JNKi

:   JNK inhibitor SP600125

MAP kinase

:   mitogen-activated protein kinase

Mcl-1

:   myeloid cell leukemia sequence 1

MOMP

:   Mitochondrial outer membrane permeabilization

MPT

:   mitochondrial permeability transition

O~2~

:   superoxide

OCR

:   oxygen consumption rate

Ox-Phos

:   oxidative phosphorylation

PERK

:   eukaryotic translation initiation factor 2-alpha kinase

PMH

:   primary mouse hepatocyte

RCR

:   respiratory-control-ratio

Reserve-capacity

:   reserve oxidative capacity

RIP1

:   receptor-interacting serine-threonine kinase1

ROS

:   reactive oxygen species

Sab

:   SH3 homology associated BTK binding protein

sXBP1

:   spliced X-box binding protein 1

Tm

:   tunicamycin

TNF

:   tumor necrosis factor

TRAF2

:   TNF receptor-associated factor 2

UPR

:   unfolded protein response

XBP1

:   X-box binding protein 1
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![Tunicamycin induced cell death and inhibition of mitochondrial respiration. (**a**) Cell death (Sytox-green staining) at 24 h after tunicamycin (Tm) 10 and 20 *μ*g/ml treatment (Tm10 and Tm20); \**P*\<0.01 *versus* DMSO. Z-VAD-fmk (10 *μ*M) prevented tunicamycin-induced cell death; \#*P*\<0.01 *versus* Tm20. *N*=6 experiments. (**b**) Quantitation of immunostained active cleaved-caspase-3 positive cells after tunicamycin treatment; \**P*\<0.01 *versus* DMSO. *N*=3 experiments. (**c**) Cytochrome *c* released after tunicamycin treatment (confocal image; 63X magnification). (**d**) Real-time continuous measurement of cellular and mitochondrial respiration (OCR) using in Seahorse XF24 analyzer. After acquisition of basal (starting) OCR, DMSO or tunicamycin 10--20 *μ*g/ml was injected (marked as X/Y). Mitochondrial OCR after injection oligomycin (O), CCCP (C) or rotenone (R) was acquired at the end of cellular OCR measurement. No loss of viability was observed during these incubations (not shown). (**e**) Mitochondrial Ox-Phos OCR (OCR at 1 or 2 h--OCR after oligomycin) reflecting mitochondrial ATP generation, mitochondrial reserve-capacity (OCR after 1 or 2 h--OCR after CCCP), and proton leak (OCR after oligomycin--OCR after rotenone injection) were calculated from acquired mitochondrial OCR. The data are presented as mean±S.D. Mean of five wells for each experiment; \**P*\<0.05 *versus* DMSO, *N*=5 experiments](cddis2013522f1){#fig1}

![Effect of ER stress induced P-JNK activation on mitochondrial respiration and PMH death. (**a**) 20 *μ*g/ml tunicamycin treatment increased P-JNK above basal for 8 h; \**P*\<0.05 *versus* DMSO. (**b**) JNKi blocked basal and tunicamycin 20 *μ*g/ml induced JNK activation, but P-PERK activation and CHOP expression were not affected; \**P*\<0.05 *versus* no JNKi at each time by densitometry, *N*=5 experiments. (**c**) JNKi prevented tunicamycin 20 *μ*g/ml inhibition of mitochondrial Ox-Phos and reserve-capacity. The data are presented as means±S.D of five wells of each sample for each experiment, \**P*\<0.05, *N*=5 experiments. (**d**) SP600125 (JNKi) 20 *μ*M prevented tunicamycin 20 *μ*g/ml induced PMH death, \**P*\<0.01, *N*=5 experiments. (See also [Supplementary Figure S1](#sup1){ref-type="supplementary-material"})](cddis2013522f2){#fig2}

![Effect of knockdown of Sab or Sab~KIM1~ peptide on ER stress induced sustained P-JNK activation, PMH death and cellular and mitochondrial respiration. (**a**) PMH were isolated 10 days after tail-vein injection with adenoviral shlacZ or shSab. shSab efficiently depleted Sab protein. Knockdown of Sab suppressed sustained JNK activation (1--8 h); \**P*\<0.05 *versus* shlacZ, *N*=5 experiments. The increase of P-PERK activation and CHOP expression were not changed by knockdown of Sab. (**b**) Knockdown of Sab blunted JNK activation at 30 and 45 min after tunicamycin treatment but not initial activation at 15 min. (**c**) XBP1(S) (spliced form) was observed at same time after tunicamycin treatment of PMH without or with Sab knockdown. (**d**) Knockdown of Sab inhibited tunicamycin-induced cell death by SYTOX-green assay; \**P*\<0.01 *versus* shlacZ, *N*=5 experiments. (**e**) Tunicamycin inhibition of OCR was prevented by knockdown of Sab during 2 h continuous tracing after tunicamycin injection; \**P*\<0.05, *N*=5 experiments. Tunicamycin 20 *μ*g/ml injection was marked as 'Y\'. Oligomycin (O), CCCP (C), Rotenone (R). (**f**) Wild type PMH cellular OCR, mitochondrial oxidative-phosphorylation, and mitochondrial reserve oxidative capacity were measured for 2 h after injection of DMSO or tunicamycin with control scrambled peptide (Ctl) or Sab~KIM1~ peptide (KIM1) 10 *μ*M; \**P*\<0.05 Ctl peptide *versus* KIM1 peptide or Tm20 *versus* DMSO, *N*=5 experiments. The data are presented as mean±S.D. Mean of five wells of each experiment. (See also [Supplementary Figure S2](#sup1){ref-type="supplementary-material"})](cddis2013522f3){#fig3}

![Effect of antioxidant BHA on ER stress induced JNK activation and effect of activated JNK on mitochondrial ROS production. (**a**) Sustained JNK activation (1--8 h) was inhibited by BHA 100 *μ*M preincubation before tunicamycin treatment. Induction of P-PERK, CHOP, and GRP78 expression were not changed by BHA preincubation; \**P*\<0.05 *versus* vehicle control without BHA, *N*=3 experiments. (**b**) BHA suppressed JNK activation at 30 and 45 min after tunicamycin treatment but not at 15 min (initial activation). (**c**) BHA prevented tunicamycin-induced cell death; \**P*\<0.01 *versus* Tm20, *N*=3 experiments. (**d**) Sab~KIM1~ peptide blocks superoxide (O~2~^•−^) produced from mitochondria. To wild type isolated mitochondria (20 *μ*g) in respiration buffer with pyruvate/malate, premixed 10 ng recombinant active P-JNK (JNK~(a)~), ATP and control scrambled peptide or Sab~KIM1~ peptide 10 *μ*M with MitoSOX (Invitrogen) was added. Superoxide (O~2~^•−^) produced from isolated mitochondria at unstimulated basal (state II) respiration was measured intermittently by Omega fluorescence microplate reader. Sab~KIM1~ peptide blocked superoxide (O~2~^•−^) production. The data are presented as means±S.D. of five wells of each sample for each experiment; \**P*\<0.01 (scrambled *versus* KIM1 peptide), *N*=5 experiments. Antimycin A, as a positive control, induced superoxide (O~2~^•−^) production, which was not inhibited by KIM1 peptide (not shown). Fluorescence intensity represents the difference between absence and presence of FeTCPP (SOD mimetic). ATP or JNK~(a)~ alone did not significantly increase ROS (not shown). (**e**) \[Ca^2+^\] enhanced the intensity and duration of production of mitochondrial superoxide (O~2~^•−^) by activated JNK (JNK~(a)~). Inactive JNK (JNK~(m)~) with or without ATP did not increase ROS. (See also [Supplementary Figures S3 and S4](#sup1){ref-type="supplementary-material"}). (**f**) Model of the role of JNK, Sab, Ca^2+^ and ROS in the interplay of ER stress and mitochondria in sustained JNK activation](cddis2013522f4){#fig4}
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